Research published in The Lancet Public Health journal landed on a number different than the 10,000 daily step​ ...

Increasing your step count to this number can reduce your risk of diabetes, heart disease, dementia, cancer death and more, a ...

Exercise really does reduce the risk of chronic diseases such as cancer, according to a new study. And doctors should survey ...

Dry scrubbing, an age-old practice gaining popularity, involves using a coarse brush to exfoliate skin and stimulate the ...

Aiming for 7,000 daily steps can reduce risk of chronic diseases, cognitive decline, and even death, finds new study.

The results of the survey were then compared to the presence of chronic health conditions, such as cardiovascular disease and cancer. The results of this study showed that patients who reported the ...

In 2020, Ozempic was given the green light to reduce the risk of significant cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.

Ozempic is now FDA-approved to reduce chronic kidney disease risks in diabetes patients. A Phase 3 trial showed Ozempic reduced kidney disease worsening by 24% and heart-related deaths by 5%.

Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease Publish Date March 21, 2025 The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers.

Ozempic, the GLP-1 drug initially approved by the U.S. Food and Drug Administration in 2017 to treat Type 2 diabetes, was recently OK’d to help reduce risks linked to chronic kidney disease (CKD).